Society for Integrative Oncology (SIO) shared a post on LinkedIn:
“As part of our series highlighting the new Comprehensive Integrative Oncology textbook, Dr. Lu shares an overview of Chapter 33: ‘Oncology acupuncture: Integrative strategies for symptom management across the cancer care continuum ‘.
Dr. Weidong Lu, MB, MPH, PhD, is a leading expert in oncology acupuncture at the Leonard P. Zakim Center for Integrative Therapies within the Dana-Farber Cancer Institute (DFCI).
In addition to his clinical leadership at this top-tier Harvard Medical School affiliate, he serves as a Principal Investigator at Dana-Farber/Harvard Cancer Center and heads the Chinese Medicine Research Initiative.
Dr. Lu holds academic appointments at Harvard Medical School and the New England School of Acupuncture, and he currently chairs the Committee on Acupuncture for the Massachusetts Board of Registration in Medicine.
Other articles featuring SIO on OncoDaily.